The Many Faces of Tau
暂无分享,去创建一个
Meaghan Morris | S. Maeda | K. Vossel | L. Mucke | M. Morris
[1] Charless C. Fowlkes,et al. Alzheimer’s Disease Neuroimaging Initiative , 2005 .
[2] R. Schirmer,et al. “Lest we forget you — methylene blue …” , 2011, Neurobiology of Aging.
[3] M. Kamboh,et al. Emerging Histomorphologic Phenotypes of Chronic Traumatic Encephalopathy in American Athletes , 2011, Neurosurgery.
[4] J. Trojanowski,et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.
[5] Rudi D'Hooge,et al. Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.
[6] Julie R. Leitz,et al. Tau Protein Is Required for Amyloid β-Induced Impairment of Hippocampal Long-Term Potentiation , 2011, The Journal of Neuroscience.
[7] E. Mandelkow,et al. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.
[8] L. Mucke,et al. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[9] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[10] L. Buée,et al. Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.
[11] Q. Tian,et al. Essential role of tau phosphorylation in adult hippocampal neurogenesis , 2010, Hippocampus.
[12] V. Haroutunian,et al. Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.
[13] Julie A. Harris,et al. Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.
[14] Jason E Gestwicki,et al. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden , 2010, Molecular Neurodegeneration.
[15] Y. Jho,et al. Monte carlo simulations of tau proteins: effect of phosphorylation. , 2010, Biophysical Journal.
[16] Yadong Huang,et al. Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.
[17] J. Trojanowski,et al. Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy , 2010, The Journal of Neuroscience.
[18] Kai Zhang,et al. Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.
[19] S. Maeda,et al. Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss* , 2010, The Journal of Biological Chemistry.
[20] S. Yen,et al. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy , 2010, Neuropathology and applied neurobiology.
[21] E. Mandelkow,et al. Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.
[22] A. Cuervo,et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation , 2010, Neurobiology of Disease.
[23] D. Wilcock,et al. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.
[24] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[25] N. Grigoriadis,et al. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice , 2010, Experimental Neurology.
[26] Sangmook Lee,et al. Secretion of human tau fragments resembling CSF‐tau in Alzheimer's disease is modulated by the presence of the exon 2 insert , 2010, FEBS letters.
[27] M. Hellerstein,et al. Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice , 2010, Neuroscience.
[28] K. Zahs,et al. Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.
[29] J. Luebke,et al. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs , 2010, Experimental Neurology.
[30] J. L. Cantero,et al. Role of tau protein on neocortical and hippocampal oscillatory patterns , 2010, Hippocampus.
[31] K. Blennow,et al. CSF biomarkers predict a more malignant outcome in Alzheimer disease , 2010, Neurology.
[32] C. Jack,et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects , 2010, Alzheimer's & Dementia.
[33] Joseph V. Hajnal,et al. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T) , 2010, NeuroImage.
[34] D. Campion,et al. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein , 2010, Journal of Neurochemistry.
[35] Gloria Lee,et al. Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding* , 2010, The Journal of Biological Chemistry.
[36] B. Hyman,et al. Caspase activation precedes and leads to tangles , 2010, Nature.
[37] T. Zako,et al. Amyloid oligomers: formation and toxicity of Aβ oligomers , 2010, The FEBS journal.
[38] M. Schumacher,et al. A role for FKBP52 in Tau protein function , 2010, Proceedings of the National Academy of Sciences.
[39] A. Sun,et al. Deletion of tau attenuates heat shock‐induced injury in cultured cortical neurons , 2010, Journal of neuroscience research.
[40] K. Herrup. Faculty Opinions recommendation of Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. , 2009 .
[41] R. Brandt,et al. Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau , 2009, The Journal of Neuroscience.
[42] R. He,et al. The proline-rich domain of tau plays a role in interactions with actin , 2009, BMC Cell Biology.
[43] E. Mandelkow,et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.
[44] Gloria Lee,et al. Microtubule‐associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions , 2009, Journal of cellular biochemistry.
[45] M. Blackledge,et al. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules. , 2009, Biochemistry.
[46] J. Bol,et al. Transglutaminases and Transglutaminase‐Catalyzed Cross‐Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain , 2009, Brain Pathology.
[47] Bruce H. Morimoto,et al. Addressing Alzheimer's disease tangles: from NAP to AL-108. , 2009, Current Alzheimer research.
[48] E. Sigurdsson. Tau-focused immunotherapy for Alzheimer's disease and related tauopathies. , 2009, Current Alzheimer research.
[49] B. Hyman,et al. Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy , 2009, Journal of neuropathology and experimental neurology.
[50] H. Möller,et al. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. , 2009, The Journal of clinical psychiatry.
[51] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[52] Xiongwei Zhu,et al. Tau – an inhibitor of deacetylase HDAC6 function , 2009, Journal of neurochemistry.
[53] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[54] Yi Li,et al. Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases , 2009, Journal of neurochemistry.
[55] A. Lieberman,et al. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. , 2009, Human molecular genetics.
[56] G. Santpere,et al. LRRK2 and neurodegeneration , 2009, Acta Neuropathologica.
[57] P. L. Peng,et al. Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity , 2008, Neuron.
[58] S. Maeda,et al. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. , 2008, Current Alzheimer research.
[59] E. Mandelkow,et al. Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation* , 2008, Journal of Biological Chemistry.
[60] A. Takashima,et al. GSK-3β Is Required for Memory Reconsolidation in Adult Brain , 2008, PLoS ONE.
[61] L. Mucke,et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.
[62] A. Lieberman,et al. The pathogenesis of Niemann–Pick type C disease: a role for autophagy? , 2008, Expert Reviews in Molecular Medicine.
[63] T. Gura. Hope in Alzheimer's fight emerges from unexpected places , 2008, Nature Network Boston.
[64] E. Bigio,et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.
[65] R. Berry,et al. A possible link between astrocyte activation and tau nitration in Alzheimer's disease , 2008, Neurobiology of Disease.
[66] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[67] M. Zvelebil,et al. Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.
[68] D. Holtzman,et al. Active and passive immunotherapy for neurodegenerative disorders. , 2008, Annual review of neuroscience.
[69] A. Harada,et al. Neuron-specific recombination by Cre recombinase inserted into the murine tau locus. , 2008, Biochemical and Biophysical Research Communications - BBRC.
[70] J. Ávila,et al. Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells , 2008, Molecular and Cellular Neuroscience.
[71] F. Gage,et al. Mechanisms and Functional Implications of Adult Neurogenesis , 2008, Cell.
[72] Ram Dixit,et al. Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.
[73] Aidong Yuan,et al. Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice , 2008, The Journal of Neuroscience.
[74] H. Bujard,et al. The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.
[75] J. Luchsinger,et al. Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms , 2007, The Journal of Neuroscience.
[76] D. Dias-Santagata,et al. Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. , 2007, Molecular biology of the cell.
[77] O. Touloumi,et al. Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model , 2007, Journal of Pharmacology and Experimental Therapeutics.
[78] S. Maeda,et al. Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain , 2007, Journal of Neuroscience Research.
[79] Ayodeji A. Asuni,et al. Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements , 2007, The Journal of Neuroscience.
[80] L. Mucke,et al. Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.
[81] John Q Trojanowski,et al. High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. , 2007, Biochemical and biophysical research communications.
[82] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[83] S. Maeda,et al. Assembly of two distinct dimers and higher‐order oligomers from full‐length tau , 2007, The European journal of neuroscience.
[84] K. Ashe,et al. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy , 2007, The Journal of Neuroscience.
[85] Hyonchol Kim,et al. Granular tau oligomers as intermediates of tau filaments. , 2007, Biochemistry.
[86] G. Collingridge,et al. LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.
[87] K. Bhaskar,et al. Tau impacts on growth-factor-stimulated actin remodeling , 2007, Journal of Cell Science.
[88] Cam Patterson,et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.
[89] Tudor A. Fulga,et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.
[90] T. Arendt,et al. Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus , 2007, Hippocampus.
[91] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[92] G. Johnson,et al. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. , 2006, Current Alzheimer research.
[93] A. Erisir,et al. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid , 2006, The Journal of cell biology.
[94] M. Farrer,et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology , 2006, Neurology.
[95] J. Ávila,et al. Extracellular tau is toxic to neuronal cells , 2006, FEBS letters.
[96] I. Gozes,et al. Peptide neuroprotection through specific interaction with brain tubulin , 2006, Journal of neurochemistry.
[97] M. Rasenick,et al. Tau associates with actin in differentiating PC12 cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] T. Iwatsubo,et al. P4-261 Small molecule inhibitors of alpha-synuclein filament assembly , 2006, Alzheimer's & Dementia.
[99] Stefani N. Thomas,et al. Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation* , 2006, Journal of Biological Chemistry.
[100] T. Iwatsubo,et al. Small Molecule Inhibitors of α-Synuclein Filament Assembly† , 2006 .
[101] P. Fraser,et al. Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.
[102] L. Qiang,et al. Tau Protects Microtubules in the Axon from Severing by Katanin , 2006, The Journal of Neuroscience.
[103] K. Gengyo-Ando,et al. Progressive neurodegeneration in C. elegans model of tauopathy , 2005, Neurobiology of Disease.
[104] S. Yen,et al. Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.
[105] L. Mucke,et al. Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[106] Bin Zhang,et al. Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies , 2005, The Journal of Neuroscience.
[107] R. Takahashi,et al. In vivo evidence of CHIP up‐regulation attenuating tau aggregation , 2005, Journal of neurochemistry.
[108] D. Mann,et al. Visualization of Newly Deposited tau in Neurofibrillary Tangles and Neuropil Threads , 2005, Journal of neuropathology and experimental neurology.
[109] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[110] Makoto Hashimoto,et al. Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease , 2005, Neuron.
[111] Roman Rouzier,et al. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[112] Adriana B Ferreira,et al. The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.
[113] W. Noble,et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[114] Takeshi Iwatsubo,et al. Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.
[115] E. Mandelkow,et al. Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells* , 2005, Journal of Biological Chemistry.
[116] F. van Leuven,et al. Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.
[117] W. Albers,et al. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons , 2005, EMBO Journal.
[118] Chi Li,et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[119] Martin von Bergen,et al. Tau aggregation is driven by a transition from random coil to beta sheet structure. , 2005, Biochimica et biophysica acta.
[120] J. W. Rudy,et al. Understanding contextual fear conditioning: insights from a two-process model , 2004, Neuroscience & Biobehavioral Reviews.
[121] K. Nakayama,et al. U‐box protein carboxyl terminus of Hsc70‐interacting protein (CHIP) mediates poly‐ubiquitylation preferentially on four‐repeat Tau and is involved in neurodegeneration of tauopathy , 2004, Journal of neurochemistry.
[122] L. Petrucelli,et al. P3-228 Chip and HSP70 regulate tau ubiquitination, degradation and aggregation , 2004, Neurobiology of Aging.
[123] P. Tittmann,et al. Surface-decoration of microtubules by human tau. , 2004, Journal of molecular biology.
[124] L. Mucke,et al. Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.
[125] John Hardy,et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .
[126] Tony Wyss-Coray,et al. Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.
[127] G. V. Van Hoesen,et al. Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[128] Steven P. Gygi,et al. CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.
[129] K. Jellinger. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2004, Neurology.
[130] Wolfgang Härtig,et al. Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.
[131] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[132] Bin Zhang,et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[133] C. Chirita,et al. Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro* , 2003, Journal of Biological Chemistry.
[134] J. Morrison,et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.
[135] R. Nitsch,et al. Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.
[136] M. Goedert,et al. Repeat motifs of tau bind to the insides of microtubules in the absence of taxol , 2003, The EMBO journal.
[137] T. Bird,et al. Niemann-Pick Disease Type C Yields Possible Clue for Why Cerebellar Neurons Do Not Form Neurofibrillary Tangles , 2002, Neurobiology of Disease.
[138] S. Halpain,et al. MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments , 2002, The Journal of cell biology.
[139] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[140] J. Trotter,et al. Process Outgrowth of Oligodendrocytes Is Promoted by Interaction of Fyn Kinase with the Cytoskeletal Protein Tau , 2002, The Journal of Neuroscience.
[141] E. Mandelkow,et al. Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.
[142] D. Mann,et al. Amyloid β protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype , 2001, Neuroscience Letters.
[143] M. Vitek,et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.
[144] Y. Ihara. PHF and PHF-like fibrils –cause or consequence? , 2001, Neurobiology of Aging.
[145] N. Hirokawa,et al. Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes , 2000, The Journal of cell biology.
[146] R. Brandt,et al. Interaction of Tau with the Neural Membrane Cortex Is Regulated by Phosphorylation at Sites That Are Modified in Paired Helical Filaments* , 2000, The Journal of Biological Chemistry.
[147] K. Blennow,et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.
[148] N. Hirokawa,et al. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.
[149] R. Maccioni,et al. Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.
[150] G. Lynch,et al. Lysosomal Protease Inhibitors Induce Meganeurites and Tangle-like Structures in Entorhinohippocampal Regions Vulnerable to Alzheimer's Disease , 1999, Experimental Neurology.
[151] John X. Morris,et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.
[152] M. Billingsley,et al. Alterations in Tau Phosphorylation in Rat and Human Neocortical Brain Slices Following Hypoxia and Glucose Deprivation , 1998, Experimental Neurology.
[153] E. Mandelkow,et al. Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.
[154] H. Band,et al. Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.
[155] A. Andreadis,et al. Splicing of a Regulated Exon Reveals Additional Complexity in the Axonal Microtubule‐Associated Protein Tau , 1998, Journal of neurochemistry.
[156] S. Jenkins,et al. Tau complexes with phospholipase C‐γ in situ , 1998 .
[157] P. Janmey,et al. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau. , 1997, Biophysical journal.
[158] T. Iwatsubo,et al. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex , 1997, Neuroreport.
[159] J. Trojanowski,et al. Selective Destruction of Stable Microtubules and Axons by Inhibitors of Protein Serine/Threonine Phosphatases in Cultured Human Neurons (NT2N Cells) , 1997, The Journal of Neuroscience.
[160] M. Bobinski,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[161] M. Ball,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories: Concurrences and Cautions , 1997, Neurobiology of Aging.
[162] E. Mandelkow,et al. RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.
[163] G. Hart,et al. The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.
[164] R. Crowther,et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.
[165] M. Roth,et al. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[166] J. Mandell,et al. A Spatial Gradient of Tau Protein Phosphorylation in Nascent Axons , 1996, The Journal of Neuroscience.
[167] A. Faissner,et al. Tau Binds to the Distal Axon Early in Development of Polarity in a Microtubule- and Microfilament-Dependent Manner , 1996, The Journal of Neuroscience.
[168] J. Ávila,et al. Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .
[169] Y. Ihara,et al. τ Is Widely Expressed in Rat Tissues , 1996 .
[170] S. Rhee,et al. Activation of Phospholipase C-γ by the Concerted Action of Tau Proteins and Arachidonic Acid* , 1996, Journal of Biological Chemistry.
[171] Alejandra del C. Alonso,et al. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.
[172] J. Troncoso,et al. Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins , 1996, Experimental Neurology.
[173] G. Drewes,et al. Structure, Microtubule Interactions, and Phosphorylation of Tau Protein a , 1996, Annals of the New York Academy of Sciences.
[174] R. Brandt,et al. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain , 1995, The Journal of cell biology.
[175] M. Shelanski,et al. τ Regulation of Microtubule‐Microtubule Spacing and Bundling , 1994 .
[176] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[177] J. Trojanowski,et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.
[178] J. Ávila,et al. Analysis of microtubule-associated protein tau glycation in paired helical filaments. , 1994, The Journal of biological chemistry.
[179] E. Mandelkow,et al. Domains of tau protein and interactions with microtubules. , 1994, Biochemistry.
[180] C. Surridge,et al. The difference in the binding of phosphatidylinositol distinguishes MAP2 from MAP2C and Tau. , 1994, Biochemistry.
[181] N. Hirokawa,et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.
[182] Khadija Iqbal,et al. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[183] D. Graham,et al. β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury , 1993, Neuroscience Letters.
[184] Yasuo Ihara,et al. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.
[185] E. Mandelkow,et al. The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.
[186] J. Trojanowski,et al. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.
[187] R. A. Crowther,et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.
[188] M. L. Schmidt,et al. Distribution of tau proteins in the normal human central and peripheral nervous system. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[189] M. Kirschner,et al. The primary structure and heterogeneity of tau protein from mouse brain. , 1988, Science.
[190] S. Mirra,et al. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[191] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[192] Y. Ihara,et al. One of the antigenic determinants of paired helical filaments is related to tau protein. , 1986, Journal of biochemistry.
[193] E. Nishida,et al. Calmodulin inhibits interaction of actin with MAP2 and Tau, two major microtubule-associated proteins. , 1985, Journal of Biological Chemistry.
[194] M. Kirschner,et al. Tubulin requires tau for growth onto microtubule initiating sites. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[195] M. Kirschner,et al. A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[196] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[197] J. Aubry,et al. Lithium: Updated Human Knowledge Using an Evidence-Based Approach , 2009, CNS Drugs.
[198] J. Aubry,et al. Lithium: Updated Human Knowledge Using an Evidence-Based Approach , 2009, CNS drugs.
[199] E. Sigurdsson. Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. , 2008, Journal of Alzheimer's disease : JAD.
[200] E. Bigio,et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. , 2008, Neurobiology of aging.
[201] J. Trojanowski,et al. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease , 2004, Acta Neuropathologica.
[202] R. Maccioni,et al. Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies , 2002, Journal of cellular biochemistry.
[203] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[204] Y. Barde,et al. Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.
[205] G. Johnson,et al. Tau complexes with phospholipase C-gamma in situ. , 1998, Neuroreport.
[206] J. Ávila,et al. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. , 1996, Journal of neurochemistry.
[207] Y. Ihara,et al. Tau is widely expressed in rat tissues. , 1996, Journal of Neurochemistry.
[208] M. Shelanski,et al. tau Regulation of microtubule-microtubule spacing and bundling. , 1994, Journal of Neurochemistry.